Folgen
Sabine Semrau
Sabine Semrau
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei uk-erlangen.de
Titel
Zitiert von
Zitiert von
Jahr
Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy
J Müller, G Wallukat, YG Weng, M Dandel, S Spiegelsberger, S Semrau, ...
Circulation 96 (2), 542-549, 1997
4461997
Safety and efficacy of stereotactic body radiotherapy for stage I non–small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis
M Guckenberger, M Allgäuer, S Appold, K Dieckmann, I Ernst, ...
Journal of Thoracic Oncology 8 (8), 1050-1058, 2013
2122013
SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphological and Clinicopathological Spectrum of a Recently Described Entity
A Agaimy, A Hartmann, CR Antonescu, SI Chiosea, SK El-Mofty, ...
The American journal of surgical pathology 41 (4), 458, 2017
2112017
SMARCB1 (INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms
A Agaimy, M Koch, M Lell, S Semrau, W Dudek, DL Wachter, A Knöll, ...
The American journal of surgical pathology 38 (9), 1274, 2014
1502014
Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients
M Hecht, L Zimmer, C Loquai, C Weishaupt, R Gutzmer, B Schuster, ...
Annals of Oncology 26 (6), 1238-1244, 2015
1342015
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small …
M Guckenberger, RJ Klement, M Allgäuer, S Appold, K Dieckmann, I Ernst, ...
Radiotherapy and Oncology 109 (1), 13-20, 2013
1262013
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy
M Guckenberger, RJ Klement, M Allgäuer, N Andratschke, O Blanck, ...
Radiotherapy and Oncology 118 (3), 485-491, 2016
1202016
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer
RJ Klement, M Allgäuer, S Appold, K Dieckmann, I Ernst, U Ganswindt, ...
International Journal of Radiation Oncology* Biology* Physics 88 (3), 732-738, 2014
692014
Stereotactic body radiotherapy for centrally located stage I NSCLC
DH Schanne, U Nestle, M Allgäuer, N Andratschke, S Appold, ...
Strahlentherapie und Onkologie 191 (2), 125-132, 2015
652015
Magnetic resonance imaging for brain stereotactic radiotherapy
F Putz, V Mengling, R Perrin, S Masitho, T Weissmann, J Rösch, ...
Strahlentherapie und Onkologie, 1-13, 2020
602020
6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer
S Semrau, A Bier, U Thierbach, C Virchow, P Ketterer, G Klautke, ...
Strahlentherapie und Onkologie 183 (1), 30-35, 2007
552007
Feasibility, Toxicity, and Efficacy of Short Induction Chemotherapy of Docetaxel Plus Cisplatin or Carboplatin (TP) Followed by Concurrent Chemoradio therapy for Organ …
S Semrau, F Waldfahrer, M Lell, R Linke, G Klautke, T Kuwert, M Uder, ...
Strahlentherapie und Onkologie 187 (1), 15-22, 2011
542011
Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of …
S Semrau, A Bier, U Thierbach, C Virchow, P Ketterer, R Fietkau
Strahlentherapie und Onkologie 179 (12), 823-831, 2003
522003
Increased skin and mucosal toxicity in the combination of vemurafenib with radiation therapy
R Merten, M Hecht, M Haderlein, L Distel, R Fietkau, L Heinzerling, ...
Strahlentherapie und Onkologie 190 (12), 1169-1172, 2014
472014
High‐grade histology as predictor of early distant metastases and decreased disease‐free survival in salivary gland cancer irrespective of tumor subtype
M Haderlein, C Scherl, S Semrau, S Lettmaier, W Uter, FW Neukam, H Iro, ...
Head & neck 38 (S1), E2041-E2048, 2016
462016
Primary glioblastoma multiforme tumors and recurrence
C Muth, Y Rubner, S Semrau, PF Rühle, B Frey, A Strnad, R Buslei, ...
Strahlentherapie und Onkologie 192 (3), 146-155, 2016
462016
Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments
RJ Klement, JJ Sonke, M Allgäuer, N Andratschke, S Appold, J Belderbos, ...
International Journal of Radiation Oncology* Biology* Physics, 2020
452020
Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy
S Semrau, G Klautke, JC Virchow, G Kundt, R Fietkau
Respiratory medicine 102 (2), 210-218, 2008
452008
Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx
S Semrau, D Schmidt, M Lell, F Waldfahrer, S Lettmaier, T Kuwert, H Iro, ...
Oral oncology 49 (5), 454-460, 2013
412013
Single‐cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: What are the best predictors of remission and prognosis?
S Semrau, M Haderlein, D Schmidt, M Lell, W Wolf, F Waldfahrer, M Uder, ...
Cancer 121 (8), 1214-1222, 2015
402015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20